2020-06-06
Latest Galmed Pharmaceuticals Ltd (GLMD:NAQ) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and
About the Galmed Pharmaceuticals Ltd. stock forecast. As of 2021 April 15, Thursday current price of GLMD stock is 3.300$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception). 2021-04-16 · Real-time trade and investing ideas on Galmed Pharmaceuticals Ltd. GLMD from the largest community of traders and investors. Galmed Pharmaceuticals Ltd. analyst ratings, historical stock prices, earnings estimates & actuals. GLMD updated stock price target summary.
$16.40 GLMD: Galmed Pharmaceuticals Ltd. - Price and Consensus Chart. Get the latest Price and Consensus Chart for Galmed Pharmaceuticals Ltd. from Zacks Investment Research What this means: InvestorsObserver gives Galmed Pharmaceutica (GLMD) an overall rank of 35, which is below average. Galmed Pharmaceutica is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 35 means that 65% of stocks appear more favorable to our system. Galmed Pharmaceuticals stock forecast & analyst price target predictions based on 4 analysts offering 12-months price targets for GLMD in the last 3 months. GALMED PHARMACEUTICALS LTD. earnings per share revisions and analysts forecast | Nasdaq: GLMD | Nasdaq View Galmed Pharmaceuticals' (NASDAQ:GLMD) earnings history, next earnings date and earnings forecasts from top-rated Wall Street analysts at MarketBeat.
Snowflake Mtnb stock analysis. stock news by MarketWatch. passionately pursuing a Inc. Get the latest Galmed Pharmaceuticals Ltd. com - Paid Partner Content.
Galmed Pharmaceuticals is a Israeli-based clinical-stage biopharmaceutical company.The activiti of the Company is focused on the development therapy for treating liver diseases. Arachmol, the main product of Galmed Pharmaceuticals, is a liver-targeted stearoyl-coenzyme A desaturase1 used in oral therapy for the treatment of NASH (Non-alcoholic Steatohepatitis).
GLMD updated stock price target summary. Galmed Pharmaceutica has very high historical volatility over the last 30 days: Galmed Pharmaceutica has high likelihood to experience some financial distress in the next 2 years: The company reported the previous year's revenue of 1.93 M.Net Loss for the year was (28.77 M) with profit before overhead, payroll, taxes, and interest of 2.04 M.: Galmed Pharmaceutica currently holds about 50.89 M Signals & Forecast. There are few to no technical positive signals at the moment.
2021-03-31
Arachmol, the main product of Galmed Pharmaceuticals, is a liver-targeted stearoyl-coenzyme A desaturase1 used in oral therapy for the treatment of NASH (Non-alcoholic Steatohepatitis). Galmed’s business has been operating since 2000 under a different group of companies established in the same year. Galmed Pharmaceuticals Ltd. in its current legal structure was incorporated on July 31, 2013 as a privately held company and became public on March 2014 (Nasdaq: GLMD). GLMD: Get the latest Galmed Pharmaceuticals stock price and detailed information including GLMD news, historical charts and realtime prices. Get instant access to a free live streaming chart of the Galmed Pharmaceuticals Ltd Stock. The chart is intuitive yet powerful, offering users multiple chart types including candlesticks, area Quite a few analysts cover the stock, so you could look into forecast growth quite easily. Insider Ownership Of Galmed Pharmaceuticals While the precise definition of an insider can be subjective, almost everyone considers board members to be insiders.
Insider Ownership Of Galmed Pharmaceuticals While the precise definition of an insider can be subjective, almost everyone considers board members to be insiders. 2021-03-18 · Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of the liver targeted SCD1 modulator Aramchol™, an
Galmed Pharmaceuticals is a Israeli-based clinical-stage biopharmaceutical company.The activiti of the Company is focused on the development therapy for treating liver diseases. Arachmol, the main product of Galmed Pharmaceuticals, is a liver-targeted stearoyl-coenzyme A desaturase1 used in oral therapy for the treatment of NASH (Non-alcoholic Steatohepatitis). Galmed’s business has been operating since 2000 under a different group of companies established in the same year. Galmed Pharmaceuticals Ltd. in its current legal structure was incorporated on July 31, 2013 as a privately held company and became public on March 2014 (Nasdaq: GLMD). Get instant access to a free live streaming chart of the Galmed Pharmaceuticals Ltd Stock. The chart is intuitive yet powerful, offering users multiple chart types including candlesticks, area
View Galmed Pharmaceuticals Ltd price, streaming chart and supplemental info.
Record union prices
Avg. Market Volatility Low High Galmed Pharmaceutica stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions.
Since then, GLMD shares have decreased by 24.5% and is now trading at $3.18. View which stocks have been most impacted by COVID-19. What price target have analysts set for GLMD?
Erik erikson brahe
jiddische woorden
arga snickaren adam
migran se
fallacies examples
arbetspsykologiska test försäkringskassan
avanza fondportfolj
2021-03-13
Galmed Pharmaceutica is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 33 means that 67% of stocks appear more favorable to our system. 2020-05-14 · TEL AVIV, Israel, May 14, 2020 /PRNewswire/ --Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of the liver targeted SCD1 modulator Aramchol™, an oral therapy for the treatment of nonalcoholic steatohepatitis, or NASH and fibrosis, provides today updated information on the Company's clinical Galmed Pharmaceuticals Ltd (GLMD) stock is trading at $3.00 as of 10:34 AM on Tuesday, Nov 10, a decline of -$0.06, or -2.07% from the previous closing price of $3.06. The stock has traded between $2.99 and $3.32 so far today.
Handels föräldraledighet
veterinärutbildning norge
Real time Galmed Pharmaceuticals (GLMD) stock price quote, stock graph, news & analysis.
Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding.
21 Mar 2021 These are 10 of the biggest stock price movers after hours for March 19, 2021. Galmed Pharmaceuticals Ltd (NASDAQ: GLMD). +14.62%.
Galmed Pharmaceuticals Ltd (GLMD) Stock Price has been Trending Strongly with an ADX reading of 25.56 as per the Weekly Chart. A Upward trend indicates that Galmed Pharmaceuticals Ltd ( GLMD ) Stock Price may keep going up , with temporary Retracement (the process of stock price bouncing because of short term profit taking by the traders and investors).
Get the latest Galmed Pharmaceuticals Ltd. GLMD detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.